Skip to content

Testosterone therapy and cardiovascular risk

Published: October 18, 2026Updated: October 18, 2026

Borst SE, Shaneyfelt J, Carson J

JAMA · 2016

This meta-analysis evaluates the intervention under study in relation to the primary clinical outcome. Includes 3,034 participants. Evidence level: IIa.

Quick summary

Evidence-Based Research: Testosterone Cardiovascular Risk

Medically reviewed by WellAlly Editorial TeamLast reviewed October 18, 2026Editorial policy

Key facts at a glance

DOI
10.1001/jama.2016.19657
PMID
27959791
Journal
JAMA
Year
2016
Study type
meta-analysis
Evidence level
IIa
Sample size
3034
Intervention
睾酮补充治疗
Primary outcome
心血管不良事件
Open access
false

Study Overview

This meta-analysis enrolled 3,034 participants and examined the primary clinical outcome.

Key Findings

Results regarding the primary clinical outcome are presented.

Clinical Conclusions

See original publication for detailed findings. Evidence level: IIa.

Abstract

"This meta-analysis enrolled 3,034 participants, investigating the effects of 睾酮补充治疗 on 心血管不良事件.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy

More meta analysis studies

View all